Weight management that scales without the cost spiral
A clinically proven program with published 2-year durability data, plus FDA-approved GLP-1 medication from an independent licensed clinician when a member needs it. $299 per participant per month, all in.
You already know the problem. Obesity-related costs are rising, GLP-1 pharmacy spend is surging, and the programs that work require expensive infrastructure — coaches, clinicians, or indefinite prescriptions. Meanwhile, the programs that scale haven't proven they produce durable outcomes.
Key to Health is different. It's a fully automated digital weight management program built on breath acetone biofeedback — a real-time metabolic signal that teaches people how their food choices affect their body. No coaching. No pharmacotherapy. Published outcomes at 2 years. And marginal cost per additional member that approaches zero.
The challenge
GLP-1 spending is reshaping employer budgets
GLP-1 medications have demonstrated that significant weight loss is biologically achievable. But real-world employer experience tells a more complicated story: pharmacy budgets are being consumed, adherence is poor, and discontinuation leads to weight regain — negating both clinical and economic benefits.
Sources: EBRI/BCBSA simulation model (2025); Blue Health Intelligence claims analysis; Prime Therapeutics persistence data; WTW employer pulse survey (2025); SURMOUNT-4 trial; BCBSA Minnesota school district case.
And the non-pharmacological alternatives have their own gaps
Coaching-based programs
- Effective when well-implemented, but cost scales linearly with enrollment — every new member requires a human
- Coach quality varies; high turnover creates inconsistency
- Difficult to offer to entire eligible population at reasonable per-member cost
App-only programs
- Scalable and low cost, but limited clinical evidence for durable outcomes
- Most rely on calorie counting or food logging — high-burden activities with steep dropout
- No objective metabolic feedback; users are guessing whether their choices are working
The solution
A fully automated program with published outcomes
Key to Health combines a handheld breath acetone sensor with a mobile app that delivers a Mediterranean-style dietary framework — aligned with the 2026 U.S. Dietary Guidelines. When a member breathes into the device, they see a real-time measure of whether their body is burning stored fat. This biofeedback loop creates the behavioral reinforcement that sustains long-term change.
The program is entirely self-directed. There is no coaching staff, no physician oversight, and no pharmacotherapy. This means marginal cost per additional member approaches zero — making it feasible to offer to your entire eligible population, not just a high-risk subset.
The evidence
Clinical data from trial to real-world scale
Randomized controlled trial
Falkenhain et al. Obesity. 2021. Independent investigators at UBC. Funded by CIHR.
A pragmatic RCT comparing Key to Health against WW (an evidence-based active comparator, not placebo). Independently conducted, publicly funded, pre-registered.
Real-world evidence at scale
Wu et al. Obesity. 2026. Co-authored with UBC investigators. Sponsored by Key to Health.
A pre-registered, retrospective cohort study testing whether the RCT findings hold in real-world conditions — at 73× the enrollment, with 2-year follow-up, and with no coaching or physician oversight. Intention-to-treat analysis with MMRM, not just completers.
Weight loss reached 9.3% at 1 year and held at 9.6% at 2 years, in line with the RCT. To our knowledge, this is the largest published dataset with standardized 2-year weight outcomes for any non-pharmacological digital weight management program.
Read the published studyMechanism evidence: why it works
Falkenhain et al. JMIR mHealth and uHealth. 2022.
Mediation analysis showing that biofeedback engagement drove dietary adherence, which drove weight loss. This isn't a black box — there's published evidence for why the program produces outcomes, giving confidence that results are reproducible across populations.
Read the published studyHow Key to Health compares
A fair comparison of what we offer versus the alternatives employers and health plans are evaluating.
| Key to Health | GLP-1 medications | Coaching programs | App-only programs | |
|---|---|---|---|---|
| Published RCT | Yes — active comparator | Yes — extensive | Varies by vendor | Rare |
| 2-year real-world data | Yes — 9.6% at 2 years, N=11,365 (published) | Limited durability data off-drug | Rarely published | Rarely published |
| Fully automated | Yes — no humans required | Requires prescriber | No — coach-dependent | Yes |
| Ongoing medication | None | Yes — indefinitely at current evidence | None | None |
| Marginal cost per member | Low | $7,000–$12,000+/year | Scales with enrollment | Low |
| Metabolic feedback | Real-time breath acetone | N/A | N/A | N/A (some use CGM) |
| Mechanism evidence | Published — mediation analysis | Well-characterized | Varies | Rare |
| Dietary guideline alignment | 2026 U.S. Dietary Guidelines | N/A (pharmacological) | Varies | Varies |
This comparison is based on publicly available evidence and general category characteristics. Individual products within each category may differ. GLP-1 cost estimates reflect published commercial pricing analyses.
Implementation
How it fits into your benefit design
The drug when it's needed. The program for life.
One price covers Key to Health's program, an independent licensed clinician, and FDA-approved GLP-1 medication from Novo Nordisk or Eli Lilly, never compounded. Members start with two months on the program. Those who need medication then qualify for it, and step down off it at goal while the program continues.
The program alone produced ~10% weight loss at 48 weeks in an independent RCT and 9.6% at 2 years in 11,365 real-world members. Those results are without medication, not GLP-1 or step-down outcomes.
During & after GLP-1s: behavior skills for maintenance
GLP-1 medications change appetite, but they don't teach dietary skills. When members discontinue — and published data show most do within the first year — they haven't learned what to eat or how their choices affect their metabolism. Key to Health provides the dietary education and real-time metabolic feedback that supports members during GLP-1 therapy and helps them build the habits needed to maintain progress if they step down or discontinue.
Instead of GLP-1s: a standalone evidence-based option
For organizations that have excluded GLP-1 coverage for weight management — or are considering it due to cost — Key to Health offers a clinically studied alternative that can be offered to your entire eligible population. Fully automated, no coaching infrastructure, no ongoing pharmacy spend. Published real-world outcomes show 9.6% average weight loss at 2 years in an intention-to-treat analysis of 11,365 adults.
Model your savings
Adjust the inputs below to compare covering GLP-1s alone with Key to Health at $299 per participant per month, all in.
Model compares the same members for 12 months. Key to Health is $299 per participant per month, all in: the program, an independent licensed clinician, and FDA-approved GLP-1 medication when a member qualifies after two months on the program. No employee copays; billed only for active participants (2-month minimum). Program results (~10% weight loss at 48 weeks in an RCT, 9.6% at 2 years in real-world members) are without medication, not GLP-1 or step-down outcomes. Actual costs may vary.
Let's talk about your population
We're happy to walk through our clinical data, model assumptions, and discuss program design with benefits teams, health plan medical directors, and clinical partners.
Get in touch